GENEVA, May 11 -- MOCHIDA PHARMACEUTICAL CO., LTD. (7, Yotsuya 1-chome, Shinjuku-ku, Tokyo1608515), 持田製薬株式会社 (東京都新宿区四谷一丁目７番地) filed a patent application (PCT/JP2025/038230) for "NUCLEIC ACID MOLECULE INHIBITING EXPRESSION OF TSLP" on Oct 30, 2025. With publication no. WO/2026/095015, the details related to the patent application was published on May 07, 2026.
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Inventor(s): JINNO, Yasutaka (c/o MOCHIDA PHARMACEUTI...